405 related articles for article (PubMed ID: 38003674)
1. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy.
Abaza T; El-Aziz MKA; Daniel KA; Karousi P; Papatsirou M; Fahmy SA; Hamdy NM; Kontos CK; Youness RA
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003674
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
Front Immunol; 2021; 12():676922. PubMed ID: 34335575
[TBL] [Abstract][Full Text] [Related]
3. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
5. The role of circular RNAs in the development of hepatocellular carcinoma.
Hussen BM; Honarmand Tamizkar K; Hidayat HJ; Taheri M; Ghafouri-Fard S
Pathol Res Pract; 2021 Jul; 223():153495. PubMed ID: 34051512
[TBL] [Abstract][Full Text] [Related]
6. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
Wang Y; Li Z; Xu S; Guo J
J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
[TBL] [Abstract][Full Text] [Related]
7. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
8. Circular RNAs 0064286 and 0000475: Potential Diagnostic Biomarkers in Hepatocellular Carcinoma.
El Sharkawi FZ; Awad MS; Elagawy W; Al Sawaf HA; Taha H
Asian Pac J Cancer Prev; 2021 Sep; 22(9):3039-3044. PubMed ID: 34582677
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.
Sun JY; Zhang XY; Cao YZ; Zhou X; Gu J; Mu XX
J Cell Mol Med; 2020 May; 24(10):5438-5445. PubMed ID: 32281724
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
Zhao J; Wang Y; Su H; Su L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
[TBL] [Abstract][Full Text] [Related]
11. Circular RNAs in the tumour microenvironment.
Ma Z; Shuai Y; Gao X; Wen X; Ji J
Mol Cancer; 2020 Jan; 19(1):8. PubMed ID: 31937318
[TBL] [Abstract][Full Text] [Related]
12. Abnormally Expressed Circular RNAs are Promising Biomarkers for Diagnosis of Hepatocellular Carcinoma: a Meta-Analysis.
Yu G; Yang L; Zhou J; Zhang L; Xia L
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710441
[TBL] [Abstract][Full Text] [Related]
13. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
14. CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance.
Zhou Y; Mao X; Peng R; Bai D
Int J Med Sci; 2022; 19(14):2033-2043. PubMed ID: 36483595
[TBL] [Abstract][Full Text] [Related]
15. Involvement of CircRNAs in regulating The "New Generation of Cancer Hallmarks": A Special Depiction on Hepatocellular Carcinoma.
Dawoud A; Elmasri RA; Mohamed AH; Mahmoud A; Rostom MM; Youness RA
Crit Rev Oncol Hematol; 2024 Apr; 196():104312. PubMed ID: 38428701
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis.
Lei B; Zhou J; Xuan X; Tian Z; Zhang M; Gao W; Lin Y; Ni B; Pang H; Fan W
Cancer Med; 2019 Apr; 8(4):1423-1433. PubMed ID: 30714679
[TBL] [Abstract][Full Text] [Related]
17. Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma.
Zhang G; Lv X; Yang Q; Liu H
BMC Cancer; 2022 Aug; 22(1):888. PubMed ID: 35964022
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
19. Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.
Zhang Y; Wang Y
Front Oncol; 2021; 11():667428. PubMed ID: 34055634
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Research on the Role of Circular RNAs in Hepatocellular Carcinoma and Clinical Implications.
Zou RC; Li LL; Yuan HL
Med Sci Monit; 2020 Aug; 26():e923832. PubMed ID: 32779638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
